Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm von Keller, Alana L, Sherbenou, Daniel W, Forsberg, Peter A, Mark, Tomer M

Volltext

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death von Chung, Alexander H, Leisner, Tina M, Dardis, Gabrielle J, Bivins, Marissa M, Keller, Alana L, Parise, Leslie V

Volltext

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies von Perez de Acha, Olivia, Reiman, Lauren, Jayabalan, David S., Walker, Zachary J., Bosma, Grace, Keller, Alana L., Parzych, Sarah E., Abbott, Diana, Idler, Beau M., Ribadeneyra, Drew, Niesvizky, Ruben, Forsberg, Peter A., Mark, Tomer M., Sherbenou, Daniel W.

Volltext

Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies von Keller, Alana L, Reiman, Lauren T, Perez de Acha, Olivia, Parzych, Sarah E, Forsberg, Peter A, Kim, Peter S, Bisht, Kamlesh, Wang, Hongfang, van de Velde, Helgi, Sherbenou, Daniel W

Volltext

BCMAxCD3 Bispecific Antibody Elranatamab Is Effective in Patient Myeloma Relapsed after BCMA CAR-T von Keller, Alana L., Parzych, Sarah E., Reiman, Lauren T., Walker, Zachary J., Forsberg, Peter A., Sherbenou, Daniel W.

Volltext

742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (I... von Aroniadis, Olga C., Brandt, Lawrence J., Oneto, Caterina, Feuerstadt, Paul, Sherman, Alex, Wolkoff, Allan W., Downs, Ian A., Zanetti-Yabur, Alana, Ramos, Yolanda, Cotto, Candace L., Kassam, Zain, Elliott, Ryan J., Rosenbaum, Robert, Budree, Shrish, Sadovsky, Rotem Gura, Timberlake, Sonia, Swanson, Paige, Kim, Mimi, Keller, Marla J.

Volltext